Literature DB >> 15642484

The Family Investigation of Nephropathy and Diabetes (FIND): design and methods.

William C Knowler1, Josef Coresh, Robert C Elston, Barry I Freedman, Sudha K Iyengar, Paul L Kimmel, Jane M Olson, Rosemarie Plaetke, John R Sedor, Michael F Seldin.   

Abstract

BACKGROUND: The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic nephropathy. It is conducted in eight U.S. clinical centers and a coordinating center, and with four ethnic groups (European Americans, African Americans, Mexican Americans, and American Indians). Two strategies are used to localize susceptibility genes: a family-based linkage study and a case-control study using mapping by admixture linkage disequilibrium (MALD).
METHODS: In the family-based study, probands with diabetic nephropathy are recruited with their parents and selected siblings. Linkage analyses will be conducted to identify chromosomal regions containing genes that influence the development of diabetic nephropathy or related quantitative traits such as serum creatinine concentration, urinary albumin excretion, and plasma glucose concentrations. Regions showing evidence of linkage will be examined further with both genetic linkage and association studies to identify genes that influence diabetic nephropathy or related traits. Two types of MALD studies are being done. One is a case-control study of unrelated individuals of Mexican American heritage in which both cases and controls have diabetes, but only the case has nephropathy. The other is a case-control study of African American patients with nephropathy (cases) and their spouses (controls) unaffected by diabetes and nephropathy; offspring are genotyped when available to provide haplotype data.
CONCLUSIONS: Identification of genes that influence susceptibility to diabetic nephropathy will lead to a better understanding of how nephropathy develops. This should eventually lead to improved treatment and prevention.

Entities:  

Mesh:

Year:  2005        PMID: 15642484     DOI: 10.1016/j.jdiacomp.2003.12.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  47 in total

1.  Translating associations between common kidney diseases and genetic variation into the clinic.

Authors:  Paul E Drawz; John R Sedor
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

2.  Genome-wide Association Study of Platelet Count Identifies Ancestry-Specific Loci in Hispanic/Latino Americans.

Authors:  Ursula M Schick; Deepti Jain; Chani J Hodonsky; Jean V Morrison; James P Davis; Lisa Brown; Tamar Sofer; Matthew P Conomos; Claudia Schurmann; Caitlin P McHugh; Sarah C Nelson; Swarooparani Vadlamudi; Adrienne Stilp; Anna Plantinga; Leslie Baier; Stephanie A Bien; Stephanie M Gogarten; Cecelia A Laurie; Kent D Taylor; Yongmei Liu; Paul L Auer; Nora Franceschini; Adam Szpiro; Ken Rice; Kathleen F Kerr; Jerome I Rotter; Robert L Hanson; George Papanicolaou; Stephen S Rich; Ruth J F Loos; Brian L Browning; Sharon R Browning; Bruce S Weir; Cathy C Laurie; Karen L Mohlke; Kari E North; Timothy A Thornton; Alex P Reiner
Journal:  Am J Hum Genet       Date:  2016-01-21       Impact factor: 11.025

3.  Elevated male European and female African contributions to the genomes of African American individuals.

Authors:  Joanne M Lind; Holli B Hutcheson-Dilks; Scott M Williams; Jason H Moore; Myron Essex; Eduardo Ruiz-Pesini; Douglas C Wallace; Sarah A Tishkoff; Stephen J O'Brien; Michael W Smith
Journal:  Hum Genet       Date:  2006-09-28       Impact factor: 4.132

4.  A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping.

Authors:  Chao Tian; David A Hinds; Russell Shigeta; Sharon G Adler; Annette Lee; Madeleine V Pahl; Gabriel Silva; John W Belmont; Robert L Hanson; William C Knowler; Peter K Gregersen; Dennis G Ballinger; Michael F Seldin
Journal:  Am J Hum Genet       Date:  2007-06       Impact factor: 11.025

Review 5.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

6.  Examination of association with candidate genes for diabetic nephropathy in a Mexican American population.

Authors:  Sulgi Kim; Hanna E Abboud; Madeleine V Pahl; John Tayek; Susan Snyder; James Tamkin; Harry Alcorn; Eli Ipp; Cynthia C Nast; Robert C Elston; Sudha K Iyengar; Sharon G Adler
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

7.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Comeau; Jasmin Divers; Anthony J Bleyer; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2009-06-30       Impact factor: 5.992

8.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Authors:  Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2016-09-22

9.  Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

Authors:  Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle
Journal:  J Diabetes Complications       Date:  2016-07-27       Impact factor: 2.852

10.  Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity.

Authors:  Sapna Gangaputra; James F Lovato; Larry Hubbard; Matthew D Davis; Barbara A Esser; Walter T Ambrosius; Emily Y Chew; Craig Greven; Letitia H Perdue; Wai T Wong; Audree Condren; Charles P Wilkinson; Elvira Agrón; Sharon Adler; Ronald P Danis
Journal:  Retina       Date:  2013 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.